User menu

Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.

Bibliographic reference Leclercq, Isabelle ; Desager, J P ; Horsmans, Y. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.. In: Clinical pharmacology and therapeutics, Vol. 64, no. 2, p. 144-9 (1998)
Permanent URL http://hdl.handle.net/2078.1/70985
  1. Guengerich F. P., Chem Res Toxicol, 4, 168 (1991)
  2. Koop D. R., FASEB J, 6, 724 (1992)
  3. O'Shea D., Clin Pharmacol Ther, 56, 359 (1994)
  4. Zand R., Clin Pharmacol Ther, 54, 142 (1993)
  5. O'Shea D., Br J Clin Pharmacol, 43, 99 (1997)
  6. Chung F. L., Cancer Res, 52, 2719S (1992)
  7. Guo Z., Cancer Res, 51, 4798 (1991)
  8. Smith T. J., Cancer Res, 50, 6817 (1990)
  9. Guo Z., Arch Biochem Biophys, 298, 279 (1992)
  10. Chen L., Clin Pharmacol Ther, 60, 651 (1996)
  11. Raucy J. L., Arch Biochem Biophys, 271, 270 (1989)
  12. Patten C. J., Chem Res Toxicol, 6, 511 (1993)
  13. Thummel K. E., Biochem Pharmacol, 45, 1563 (1993)
  14. Lucas D., J Chrom Biomed applications, 622, 79 (1993)
  15. Chung F. L., Cancer Epidemiol Biomark Prevent, 1, 383 (1992)
  16. Peter Raimund, Boecker Ronald, Beaune Philippe H., Iwasaki Masahiko, Guengerich F. Peter, Yang Chung S., Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1, 10.1021/tx00018a012
  17. Yamazaki H., Drug Metabolism Dispos, 23, 438 (1995)
  18. Kim R. B., J Pharmacol Exp Ther, 279, 4 (1996)
  19. Girre C., Biochem Pharmacol, 47, 1503 (1994)
  20. Lucas D., Pharmacogenetics, 5, 298 (1995)
  21. Vesell E. S., Pharmacogenetics, 5, 53 (1995)
  22. Ono S., Pharmacogenetics, 5, 143 (1995)
  23. Court M. H., Biopharm Drug Dispos, 18, 213 (1997)
  24. Kharasch E. D., Clin Pharmacol Ther, 53, 643 (1993)
  25. Gorski J. C., Xenobiotica, 3, 243 (1997)